Stay updated on Tislelizumab After Liver-Directed Therapy Clinical Trial

Sign up to get notified when there's something new on the Tislelizumab After Liver-Directed Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tislelizumab After Liver-Directed Therapy Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.5.3, replacing v3.5.2. This reflects a minor internal version update and does not change study data or publicly visible content.
    Difference
    0.1%
    Check dated 2026-04-30T18:33:53.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.2, replacing the previous Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T10:35:31.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Added Hepatocellular carcinoma as a condition term. Linked the Genetic and Rare Diseases Information Center resource and updated revision from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-18T18:04:04.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T17:49:42.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the government funding/operating status notice (and Revision: v3.4.1) from the page.
    Difference
    0.4%
    Check dated 2026-02-11T02:40:47.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    Added a government-funding notice and updated the site revision to v3.4.1, replacing the prior v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T00:25:20.000Z thumbnail image

Stay in the know with updates to Tislelizumab After Liver-Directed Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tislelizumab After Liver-Directed Therapy Clinical Trial page.